Danaher Long-Term Investments 2010-2024 | DHR
Danaher long-term investments from 2010 to 2024. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
- Danaher long-term investments for the quarter ending September 30, 2024 were $M, a NAN% increase year-over-year.
- Danaher long-term investments for 2023 were $0B, a NAN% decline from 2022.
- Danaher long-term investments for 2022 were $0B, a NAN% decline from 2021.
- Danaher long-term investments for 2021 were $0B, a NAN% decline from 2020.
Danaher Annual Long-Term Investments (Millions of US $) |
2023 |
$ |
2022 |
$ |
2021 |
$ |
2020 |
$ |
2019 |
$ |
2018 |
$ |
2017 |
$ |
2016 |
$ |
2015 |
$ |
2014 |
$ |
2013 |
$ |
2012 |
$548 |
2011 |
$522 |
2010 |
$511 |
2009 |
$ |
Danaher Quarterly Long-Term Investments (Millions of US $) |
2024-09-30 |
|
2024-06-30 |
|
2024-03-31 |
|
2023-12-31 |
|
2023-09-30 |
|
2023-06-30 |
|
2023-03-31 |
|
2022-12-31 |
|
2022-09-30 |
|
2022-06-30 |
|
2022-03-31 |
|
2021-12-31 |
|
2021-09-30 |
|
2021-06-30 |
|
2021-03-31 |
|
2020-12-31 |
|
2020-09-30 |
|
2020-06-30 |
|
2020-03-31 |
|
2019-12-31 |
|
2019-09-30 |
|
2019-06-30 |
|
2019-03-31 |
|
2018-12-31 |
|
2018-09-30 |
|
2018-06-30 |
|
2018-03-31 |
|
2017-12-31 |
|
2017-09-30 |
|
2017-06-30 |
|
2017-03-31 |
|
2016-12-31 |
|
2016-09-30 |
|
2016-06-30 |
|
2016-03-31 |
|
2015-12-31 |
|
2015-09-30 |
|
2015-06-30 |
|
2015-03-31 |
|
2014-12-31 |
|
2014-09-30 |
|
2014-06-30 |
|
2014-03-31 |
|
2013-12-31 |
|
2013-09-30 |
|
2013-06-30 |
|
2013-03-31 |
|
2012-12-31 |
$548 |
2012-09-30 |
$561 |
2012-06-30 |
$553 |
2012-03-31 |
$550 |
2011-12-31 |
$522 |
2011-09-30 |
$531 |
2011-06-30 |
$533 |
2011-03-31 |
$523 |
2010-12-31 |
$511 |
2010-09-30 |
$499 |
2010-06-30 |
|
2010-03-31 |
|
2009-12-31 |
|
2009-09-30 |
|
2009-06-30 |
|
2009-03-31 |
|
Sector |
Industry |
Market Cap |
Revenue |
Multi-Sector Conglomerates |
Diversified Operations |
$163.350B |
$23.890B |
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally.
|